Publication: 308

Topoisomerase IIα Amplification Does Not Predict Benefit From Dose-Intense Cyclophosphamide, Doxorubicin, and Fluorouracil Therapy in HER2-Amplified Early Breast Cancer: Results of CALGB 8541/150013
      QxMD      Google Scholar   
Citation:
J Clin Oncol vol 27 (21) 3430-3436
Year:
2009
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
TRP
Primary Committee:
Correl Sci NOS
Sec. Committees:
   
Pharmas:
 
Grants:
P30 CA016672  
Corr. Author:
 
Authors:
                             
Networks:
 
Study
CALGB-150013
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-8541
Phases:
N/A, 3
Keywords:
Bios3, Bios4, Bc5, Bc8, To2, To3, ORIGINAL REPORTS, Breast Cancer